Dexmedetomidine for Sedation in Patients Requiring Mechanical Ventilation is Associated With a Lower Incidence of Delirium
1 other identifier
observational
412
0 countries
N/A
Brief Summary
This retrospective cohort study will include 412 adults mechanically ventilated \>24 hours in intensive care unit in sohag university hospital between 2024 and 2026). Participants will be assigned to either, EGDS group ( equal to 208 ) or conventional sedation group (equal to 204 ). The main endpoint will be measured is the incidence of delirium in ICU , measured by the Confusion Assessment Method for the ICU (CAM-ICU). Secondary endpoints will be the number of the days free from ventilation at 28 days (VFDs), ICU length of stay (LOS) in the ICU, and the death during hospitalization.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Aug 2026
Shorter than P25 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 20, 2026
CompletedFirst Submitted
Initial submission to the registry
August 24, 2026
CompletedFirst Posted
Study publicly available on registry
September 8, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
January 20, 2027
September 8, 2026
August 1, 2026
2 months
August 24, 2026
September 1, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
occurrence of delirium during the ICU admission
main end point: occurrence of delirium during the ICU admission , defined as at least one positive CAM-ICU assessment.
Within 12 hours of intubation
Secondary Outcomes (2)
Number of Ventilator-free days (VFDs)
6 months
duration of ICU stay (LOS)
6 months
Study Arms (2)
EGDS Group: Patients managed per the institutional EGDS protocol initiated within 12 hours of intuba
· EGDS Group: Patients managed per the institutional EGDS protocol initiated within 12 hours of intubation. The protocol mandated: a) Primary sedative: Dexmedetomidine infusion (loading dose optional, maintenance 0.2-1.5 µg/kg/hr). b) Goal: Target Richmond Agitation-Sedation Scale (RASS) score of 0 to -2. c) Adjunct Analgesia: Scheduled acetaminophen and opioid infusion (e.g., fentanyl) for pain control (CPOT target \<3). d) Protocol Deviations: Propofol was allowed as a rescue for refractory agitation (RASS \>+2) after optimizing analgesia
Conventional Sedation Group: Patients managed at the discretion of the treating intensivist without
Conventional Sedation Group: Patients managed at the discretion of the treating intensivist without a mandated protocol. This typically involved continuous infusions of propofol and/or midazolam, with or without dexmedetomidine, with variable RASS targets
Eligibility Criteria
this retrospective observational trial was conducted in a 40-bed intensive care unit at sohag university hospital between January 2024, to ,march 2026. The Institutional Review Board granted approval for the trial protocol and informed consent was waived
You may qualify if:
- Consecutive adult patients aged 18 years or older who required invasive mechanical ventilation for more than 24 hours.
You may not qualify if:
- Neurological primary admission such as stroke or traumatic brain injury.
- Active seizures or alcohol withdrawal at admission.
- Prior dementia or severe cognitive impairment.
- Mechanical ventilation \<24 hours.
- Death within 48 hours of admission.
- Missing essential sedation or delirium data.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Sohag Universitylead
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant professor of Anesthesia and Intensive Care
Study Record Dates
First Submitted
August 24, 2026
First Posted
September 8, 2026
Study Start
August 20, 2026
Primary Completion (Estimated)
November 1, 2026
Study Completion (Estimated)
January 20, 2027
Last Updated
September 8, 2026
Record last verified: 2026-08